Know What's Happening in Technology

Orca Adds $250M in Financing to Back Launch of T Cell Therapy
NewsJan 9, 2026

Orca Adds $250M in Financing to Back Launch of T Cell Therapy

Orca Bio announced it has raised $250 million in new financing to support the commercial launch of its T‑cell therapy designed to treat complications from allogeneic stem cell transplants. The capital infusion comes from a mix of venture capital firms and...

By Endpoints News
Use of XMRig Cryptominer by Threat Actors Expanding: Expel
NewsJan 9, 2026

Use of XMRig Cryptominer by Threat Actors Expanding: Expel

XMRig, an open‑source Monero miner, is increasingly weaponized by threat actors across Windows, Linux, Kubernetes and AWS environments. Recent campaigns have leveraged the high‑severity React2Shell exploit and UPX‑packed binaries to spread the miner via game torrents and commodity malware. Expel’s...

By Security Boulevard
Allianz, Anthropic Partner to Expand AI Use in Insurance
NewsJan 9, 2026

Allianz, Anthropic Partner to Expand AI Use in Insurance

Allianz SE has teamed up with AI specialist Anthropic to speed up responsible AI adoption across its insurance operations. The partnership targets three key initiatives: using AI to aid Allianz's software developers, automating labor‑intensive tasks like claims processing, and creating...

By Bank Automation News
Pacsun Looks Beyond the Standard App with New Co-Creation Platform
NewsJan 9, 2026

Pacsun Looks Beyond the Standard App with New Co-Creation Platform

Pacsun unveiled the PS Community Hub, a digital platform that blends social interaction, creator monetization, and co‑creation with traditional shopping. Launched in early January, the hub lets everyday users and influencers collaborate on fashion ideas, earn affiliate commissions, and shop...

By Retail TouchPoints
Transformers Hit Ceiling; Hybrid Models Unlock True Multimodal AI
SocialJan 9, 2026

Transformers Hit Ceiling; Hybrid Models Unlock True Multimodal AI

During last month’s NeurIPS 2025 conference, YC’s @agupta sat down with @krandiash, founder and CEO of Cartesia, to explain why today’s AI architectures may be fundamentally limited. They discuss how transformers act more like retrieval systems than learning systems, where new...

By YCombinator
Biotech Deal Surge: Wnt, NLRP3, GLP‑1, and More
SocialJan 9, 2026

Biotech Deal Surge: Wnt, NLRP3, GLP‑1, and More

Your Weekly Biotech News Fix | Ep. 901 Designed to be consumed as a quick scroll 🧬 Parabilis - $305M Wnt bet 🔥 $LLY - Buys $VTYX (NLRP3) 🎯 $PFE - Cartography antigen deal 🧲 $AMGN - Dark Blue acquisition 🦠 $GSK / $IONS - HBV...

By BowTiedBiotech
Michigan’s Zeal Credit Union to Buy Another UP Bank
NewsJan 9, 2026

Michigan’s Zeal Credit Union to Buy Another UP Bank

Zeal Credit Union of Livonia, Michigan, announced it will acquire The Miners State Bank, adding five branches and roughly $144 million in assets. The deal, closing in Q4 2026, will bring Zeal’s footprint to 22 branches and about $1.1 billion in assets...

By Banking Dive
Democrats Ask Apple and Google to Remove X’s Undressing Bot From Their App Stores
NewsJan 9, 2026

Democrats Ask Apple and Google to Remove X’s Undressing Bot From Their App Stores

Senators Ron Wyden, Ben Ray Luján and Ed Markey wrote to Apple CEO Tim Cook and Google CEO Sundar Pichai urging the removal of X’s AI chatbot Grok, which has been generating non‑consensual deepfake images that undress women and depict...

By The Verge
IBM's AI 'Bob' Could Be Manipulated to Download and Execute Malware
NewsJan 9, 2026

IBM's AI 'Bob' Could Be Manipulated to Download and Execute Malware

IBM’s beta AI coding assistant, Bob, is vulnerable to indirect prompt injection, allowing attackers to embed hidden commands in emails or calendar entries. Researchers at Prompt Armor demonstrated that the tool can be tricked into downloading and executing arbitrary shell...

By TechRadar
GRIm Score Predicts Nivolumab Efficacy in Melanoma
NewsJan 9, 2026

GRIm Score Predicts Nivolumab Efficacy in Melanoma

A recent multicenter trial found that the Glasgow Prognostic and Immune (GRIm) score reliably predicts response to nivolumab in advanced melanoma. Patients with high GRIm scores achieved a 45% objective response rate, while low‑score patients showed markedly shorter progression‑free survival....

By Bioengineer.org
Novartis to Build Fourth US Radiotherapy Factory in Florida
NewsJan 9, 2026

Novartis to Build Fourth US Radiotherapy Factory in Florida

Novartis announced the construction of its fourth U.S. radiotherapy manufacturing facility, a 35,000‑square‑foot plant in Winter Garden, Florida. The new site is part of the company’s broader $23 billion pledge to expand domestic production across the United States. The factory will...

By Endpoints News
ROSE Metric: Essential Profitability Gauge for SaaS
SocialJan 9, 2026

ROSE Metric: Essential Profitability Gauge for SaaS

Free SaaS Template Fridays 📈 All paths to profitability lead to the ROSE Metric. I created the ROSE Metric years ago, b/c Revenue per FTE can be very misleading. And Rev per FTE is thrown around so much that we've...

By Ben Murray
Tuina Vs. Physiotherapy: Pain Management in Chronic Back Pain
NewsJan 9, 2026

Tuina Vs. Physiotherapy: Pain Management in Chronic Back Pain

A new comparative review examines Tuina massage versus conventional physiotherapy for chronic back pain management. The analysis cites recent randomized trials indicating both modalities achieve similar reductions in pain intensity for mild-to-moderate cases. Tuina’s manual pressure and meridian focus contrast...

By Bioengineer.org
Smart Leggings Boost Muscle Strength in Seniors
NewsJan 9, 2026

Smart Leggings Boost Muscle Strength in Seniors

A biotech startup unveiled smart leggings embedded with low‑level electrical stimulation and motion sensors that claim to increase muscle strength in adults over 65. In a 12‑week clinical trial, participants wearing the leggings improved grip strength by 15% and leg...

By Bioengineer.org
2026 FinTech Funding Faces Holiday Hangover
NewsJan 9, 2026

2026 FinTech Funding Faces Holiday Hangover

FinTech funding entered 2026 with a post‑holiday lull, recording only six rounds this week. Despite the thin pipeline, three mega‑deals topped $100 million, pushing total capital raised to $734 million. Cyera led the pack with a $400 million Series F that values the AI‑security...

By Fintech Global
BioNTech, UPenn Team up for $50M Seed Fund
NewsJan 9, 2026

BioNTech, UPenn Team up for $50M Seed Fund

BioNTech and the University of Pennsylvania have announced a $50 million seed‑stage venture fund focused on mRNA‑based technologies. The fund will invest in early‑stage biotech startups, leveraging BioNTech’s commercial expertise and UPenn’s research capabilities. By targeting vaccine and therapeutic platforms, the...

By Endpoints News
AI Landscape Visualized: From ML to Generative Models
SocialJan 9, 2026

AI Landscape Visualized: From ML to Generative Models

Core concepts in Artificial Intelligence — clearly mapped in one visual. From Machine Learning and Deep Learning to NLP, Computer Vision, Reinforcement Learning, Robotics, and Generative Models, this overview highlights how the AI ecosystem fits together and where each discipline...

By Giuliano Liguori
Single-Cell Tests Predict Mycobacterial Infection Outcomes
NewsJan 9, 2026

Single-Cell Tests Predict Mycobacterial Infection Outcomes

A new study demonstrates that single‑cell transcriptional profiling can accurately predict outcomes of mycobacterial infections, distinguishing patients who will progress to active disease from those who remain latent. Researchers analyzed thousands of individual immune cells from blood samples, identifying distinct...

By Bioengineer.org
Why Your Social Media Growth Stalled (And The Algorithm Isn’t The Problem)
BlogJan 9, 2026

Why Your Social Media Growth Stalled (And The Algorithm Isn’t The Problem)

The article debunks the myth that social‑media algorithms are solely to blame for stagnant growth, pointing instead to strategic missteps. It outlines 20 common pitfalls—from creating algorithm‑centric content to inconsistent posting and weak community engagement—and offers concrete fixes such as...

By BloggingWizard
MTHFD2: Key to DNA Repair and LUAD Resistance
NewsJan 9, 2026

MTHFD2: Key to DNA Repair and LUAD Resistance

Researchers have identified the mitochondrial enzyme MTHFD2 as a pivotal driver of DNA repair mechanisms that enable lung adenocarcinoma (LUAD) cells to survive chemotherapy and targeted therapies. Experimental knockdown of MTHFD2 reduces homologous recombination efficiency and sensitizes tumors to platinum‑based...

By Bioengineer.org
Macy’s to Close 14 Underperforming Stores Even as It Touts ‘Bold New Chapter’ Performance
NewsJan 9, 2026

Macy’s to Close 14 Underperforming Stores Even as It Touts ‘Bold New Chapter’ Performance

Macy’s announced the closure of 14 underperforming stores in 12 states as part of its "Bold New Chapter" transformation. CEO Tony Spring highlighted stronger results from the "Reimagine 125" pilot stores and growth in luxury banners Bloomingdale’s and Bluemercury. The...

By Retail TouchPoints
Cloudways in 60 Minutes: The Ultimate in Simplified Cloud Hosting
NewsJan 9, 2026

Cloudways in 60 Minutes: The Ultimate in Simplified Cloud Hosting

Cloudways markets itself as a managed cloud hosting platform that simplifies WordPress deployments, offering plans starting at $12 per month. The author completed a full WordPress site setup, including a WooCommerce demo, in under an hour, highlighting the platform’s intuitive...

By TechRadar
Chinese Pseudo-Company Building 3/4 Billion Dollar Rocket Factory
NewsJan 9, 2026

Chinese Pseudo-Company Building 3/4 Billion Dollar Rocket Factory

Chinese launch startup Space Epoch announced a 5.2 billion‑yuan ($740 million) factory to mass‑produce reusable, medium‑to‑large liquid‑fuel rockets that can land on sea platforms. The plant, slated to start operations soon, aims to build up to 25 rockets annually, targeting a launch...

By Behind the Black
System Can Diagnose Infections in 20 Minutes, Aiding Fight Against Drug Resistance
NewsJan 9, 2026

System Can Diagnose Infections in 20 Minutes, Aiding Fight Against Drug Resistance

Researchers from the UK and China unveiled AutoEnricher, a microfluidic‑Raman platform that identifies bacterial and fungal pathogens in just 20 minutes. Validated on 305 patient samples, the system achieved 95 % accuracy and could detect mixed infections missed by conventional cultures....

By Phys.org – Biotechnology
A Bear’s Eye View of the Zanidatamab Data in Gastric Cancer
BlogJan 9, 2026

A Bear’s Eye View of the Zanidatamab Data in Gastric Cancer

Jazz Pharmaceuticals presented zanidatamab data from the HERIZON‑GEA‑01 phase 3 trial at the ASCO GI Symposium, targeting HER2‑positive gastric cancer. The company touted the results as practice‑changing, prompting sell‑side analysts to echo the optimism. However, the stock fell 4‑5% as investors...

By Biotech Strategy Blog
Amazon Hypes Ambient AI: Always on in the Background
BlogJan 9, 2026

Amazon Hypes Ambient AI: Always on in the Background

Amazon highlighted its "ambient AI" vision at CES 2026, promising products that operate invisibly until needed. The company also announced Peter DeSantis as head of a new unit covering AGI, custom chips and quantum computing, underscoring a long‑term conviction in breakthrough...

By EcommerceBytes
The Benefits of an Immune-Directed ADC Strategy
NewsJan 9, 2026

The Benefits of an Immune-Directed ADC Strategy

Lifordi Immunotherapeutics is pursuing an immune‑directed antibody‑drug conjugate (ADC) strategy that uses the VISTA protein to deliver potent steroids directly to immune cells. VISTA’s rapid internalization allows the ADC to release its payload intracellularly, aiming to avoid the systemic toxicities...

By Pharmaceutical Technology
Eight Healthcare Tech Trends Shaping 2026 Patient Care
SocialJan 9, 2026

Eight Healthcare Tech Trends Shaping 2026 Patient Care

The 8 Biggest Healthcare Technology Trends to Watch in 2026 Healthcare tech is entering a new era: from AI diagnostics to digital wellness, these 8 trends could transform patient care and health management. Read more 👉 https://lnkd.in/e86HpWFZ #HealthTech #AI #FutureOfHealth...

By Bernard Marr
Ultrapex Pro Launches to Support ULTRAPEX Product Layering Across Diverse Usage Scenarios
NewsJan 9, 2026

Ultrapex Pro Launches to Support ULTRAPEX Product Layering Across Diverse Usage Scenarios

Ultrapex Pro has been launched as a new application within ULTRAPEX’s evolving application‑layer architecture. The product is positioned as a complementary layer rather than a replacement, aiming to clarify segmentation across diverse usage scenarios. By separating functional components at the application...

By TechBullion
The Infrastructure of Leisure: Engineering Scale and Security for Southeast Asia’s Digital Economy
NewsJan 9, 2026

The Infrastructure of Leisure: Engineering Scale and Security for Southeast Asia’s Digital Economy

Southeast Asia’s mobile‑first digital economy is forcing a shift from centralized data centers to edge‑caching architectures to overcome the region’s fragmented, island‑based connectivity. Heavy‑weight leisure apps like Mega888 now push APKs and OBBs to micro‑data centers near users, slashing latency...

By TechBullion
Latent Demand: Unseen Needs Outpace Traditional Unmet Wants
SocialJan 9, 2026

Latent Demand: Unseen Needs Outpace Traditional Unmet Wants

The concept of the problem-unaware buyer is a long-standing one, especially in tech, where the dream is to unlock and dominate a whole new market through innovation. It falls often into the category of latent demand - a very real...

By Liam Moroney
How Utility-Driven Crypto Presales Are Evolving in 2026
NewsJan 9, 2026

How Utility-Driven Crypto Presales Are Evolving in 2026

Crypto presales in 2026 have shifted from speed‑driven fundraising to utility‑focused models. Investors now demand clear token functions, realistic use cases, and phased funding structures rather than speculative hype. Projects that embed their token in payments, access or ongoing services...

By TechBullion
Hyper-Personalisation Reshapes the Future of WealthTech
NewsJan 9, 2026

Hyper-Personalisation Reshapes the Future of WealthTech

Wealth management is undergoing a shift toward hyper‑personalisation, where advice is continuously tailored using real‑time data, predictive analytics, and behavioural insights. IntellectAI’s research highlights that over 70% of high‑net‑worth individuals tie personalised advice to firm loyalty, yet many firms still...

By Fintech Global
Hacker Behind Wired.com Leak Now Selling Full 40M Condé Nast Records
NewsJan 9, 2026

Hacker Behind Wired.com Leak Now Selling Full 40M Condé Nast Records

A hacker using the alias “Lovely” is now offering nearly 40 million Condé Nast user records for sale, expanding on a prior leak of 2.3 million Wired.com accounts. The alleged dataset spans dozens of Condé Nast‑owned sites, including high‑traffic titles such as Vanity Fair,...

By HackRead
AAAI Presidential Panel – AI Reasoning
PodcastJan 9, 2026

AAAI Presidential Panel – AI Reasoning

The panel, moderated by former AAAI President Francesca Rossi, examined AI reasoning as outlined in the AAAI’s 2025 Future of AI Research report. Experts Holger Hoos and Subbarao Kambhampati discussed how to define and implement reasoning in AI, emphasizing planning...

By AIhub
Boost Growth by Optimizing Customers, Churn, and Sales Focus
SocialJan 9, 2026

Boost Growth by Optimizing Customers, Churn, and Sales Focus

Best things to do when .. you don't know what to do: 1/ More time w/existing customers. Meet 5/mo IRL. 5/week on Zoom. 2/ Hire 1 great VP 3/ Drive down churn. You grow faster even w/o more leads 4/ Join more sales calls....

By Jason Lemkin
Digital Wealth Management: Three Trends Reshaping 2026
NewsJan 9, 2026

Digital Wealth Management: Three Trends Reshaping 2026

European wealth managers face heightened volatility, tighter regulation, and soaring digital expectations in 2026. Firms must translate abundant market data into clear, confidence‑building insights through scalable digital platforms. A premium experience now depends on intuitive interfaces, seamless onboarding, and truly...

By Fintech Global
Dashboards Show History, Not Growth Opportunities
SocialJan 9, 2026

Dashboards Show History, Not Growth Opportunities

the problem with dashboards: they don’t tell you where to grow. They tell you where you’ve been. Mid-market teams don’t lack data. They have plenty of dashboards: CAC. LTV. Funnel conversion. Segment performance. I remember attending a weekly meeting w/...

By Anna Furmanov
AI-Powered Prosthetic Hand Adapts Through Daily Use
SocialJan 9, 2026

AI-Powered Prosthetic Hand Adapts Through Daily Use

A Smarter Prosthetic: Esper Bionics’ #AI Hand Learns from Everyday Use by @EsperBionics #EmergingTech #Technology #Innovation https://t.co/hvj57gAnDV

By Ronald van Loon
Exploring Nvidia's Alpamayo, Atlas Bot, and New AI Tools
SocialJan 9, 2026

Exploring Nvidia's Alpamayo, Atlas Bot, and New AI Tools

AND WE'RE BACK... We dive into @nvidia's big Alpamayo AI car platform, Boston Dynamic's new ATLAS bot and way more AI bots. Plus, we take on Claude Code + Ralph Wiggum, OpenAI's new audio device and shout out @fofrAI's very good JSON...

By AI for Humans
Zero‑downtime Migration of 5+ PB From AWS to On‑prem
SocialJan 9, 2026

Zero‑downtime Migration of 5+ PB From AWS to On‑prem

Jeremy, a 19-year veteran of 37signals, calmly walks through the process moving 5+ petabytes of data and billions of individual files off AWS and onto our own on-prem storage setup without a second of downtime. The how, the time, and the...

By Jason Fried
CHIP Clones Raise Cardiovascular Risk in Cancer Survivors
SocialJan 9, 2026

CHIP Clones Raise Cardiovascular Risk in Cancer Survivors

More evidence that blood stem cell clones (CHIP), common with increasing age, increase the risk of cardiovascular events, from people treated with cancer https://t.co/56YDjxshjg https://t.co/kdUksoCFmI

By Eric Topol
Red Blood Cells Drive Vascular Damage in Long‑Term Type 2 Diabetes
SocialJan 9, 2026

Red Blood Cells Drive Vascular Damage in Long‑Term Type 2 Diabetes

Implicating red cells as an underpinning of the vascular damage seen with long duration Type 2 diabetes https://t.co/FzvmreCtn7 https://t.co/MdgpHmpRvo

By Eric Topol
Anthropic's Provider Lockdown Seen As Customer Hostility
SocialJan 9, 2026

Anthropic's Provider Lockdown Seen As Customer Hostility

I love the models Anthropic are offering, but I seriously hope it's a mistake that they're blocking alternative harness providers, like @opencode, from working with their subscriptions. Seems very customer hostile. https://t.co/afxEQ0XTFb

By David Heinemeier Hansson
Nominate Under‑35 Biotech Trailblazers for 2026 Award
SocialJan 9, 2026

Nominate Under‑35 Biotech Trailblazers for 2026 Award

Do you know an up and coming someone killing it in biotech? If they're under 35 years of age, please nominate them for the 2026 Technology Review 35 Innovators Under 35 Award. (or just email me. address is in bio) https://t.co/90fwj4GjNU

By Antonio Regalado
Eric Schmidt's Foundation Launches New Observatory System
SocialJan 9, 2026

Eric Schmidt's Foundation Launches New Observatory System

Former Google CEO Eric Schmidt announced late Wednesday that @schmidtsciences, one of his philanthropies, would build the Eric and Wendy Schmidt Observatory System. https://t.co/MJJA9jqN9O

By Payload
Zanidatamab Gastric Cancer Data Faces Seven Bearish Concerns
SocialJan 9, 2026

Zanidatamab Gastric Cancer Data Faces Seven Bearish Concerns

It's good to see new trial readouts at #GI26, although there are 7 reasons to be bearish about the zanidatamab data in gastric cancer: https://t.co/g2MbrPI7Iu https://t.co/tBY2yJ6YMe

By Sally Church
Stablecoins Fuel Illicit Activity, Undermining U.S. Sanctions
SocialJan 9, 2026

Stablecoins Fuel Illicit Activity, Undermining U.S. Sanctions

Stablecoins dominate illicit crypto activities, eclipsing Bitcoin Sanctions architecture challenged: Stablecoins providing dollar liquidity to sanctioned actors. Geopolitical irony - U.S.-based stablecoins undermining U.S. financial sanctions effectiveness. Regulation can't stop what's already on-chain https://t.co/3msm9cw1YP

By Efi Pylarinou
APOE Ε3/Ε4 Alleles Drive Majority of Alzheimer’s Cases
SocialJan 9, 2026

APOE Ε3/Ε4 Alleles Drive Majority of Alzheimer’s Cases

A new report claims that the APOE gene alleles accounts for the vast majority of Alzheimer's cases: "Without strong underlying risks from APOE ε3 and ε4, almost all AD and half of all dementia would not occur." https://t.co/KgRFx36WOn

By Eric Topol